Formulation, invitro and invivo evaluation of fast disintegrating tablets of rofecoxib.
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Poster
- By: SRIPERUMBUDUR, Pranitha (Kakatiya University, Uni. College of Pharm. Sci., Warangal, India)
- Co-author(s): Patlolla, Ram Reddy (Kakatiya University, WARANGAL, India)
Vobalaboina, Venkateswarlu (Kakatiya University, WARANGAL, India)
Many kinds of rapidly/fast disintegrating tablets have been developed to improve the ease of tablet administration with out any aid of water, especially for elderly and pediatric patients who feel difficulty in swallowing a tablet. Rofecoxib, a selective cyclo-oxygenase (cox-2) inhibitor is approved for the treatment of osteoarthritis, rheumatoid.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.